Search

Roland Siegwart plans to build on ETH Zurich's successful start-up ecosystem, improving support and fostering interdisciplinary cooperation.

A week before Science|Business brings together experts from Europe to discuss personalised medicine here, we look at what’s happening in the US.

As the Commission prepares to set out translations rules for the European patent on May 18, here are some helpful suggestions from Bruno Van Pottelsberghe of the Bruegel think tank.

A contest between Australia and South Africa over the world’s biggest radio telescope highlights the economic impact of ‘Big Science’.

France’s small biopharmaceutical and life science companies have been weakened by the financial crisis and had to face a drastic drop in investment in 2009.

France’s software sector has resisted the economic crisis and is innovating and creating jobs, with SMEs driving the industry, says a new report.

French innovation-focused mutual funds can make tax-efficient equity investments in ExonHit Therapeutics for renewable 3-year periods.

ACES winner Nikolaos Vlasopoulos is hoping to turn the cement industry upside down with a low-carbon, environmentally friendly variant of the old standby.

EU rules on R&D funding are too onerous, MEP Jorgo Chatzimarkakis tells Science|Business’s Anna Jenkinson.

IBM has announced the formation of its first Smarter Cities Technology Centre in Dublin, to help cities interconnect and manage core systems.

The EU’s Facility Sharing in Life Sciences project will give small and medium sized companies access to public laboratories and scientific research facilities.

Knowledge management specialist Aureus Pharma is to take part in the BioIntelligence R&D programme, part-funded by the French government.